174 related articles for article (PubMed ID: 22080620)
1. Survival after immunosuppressive therapy in children with aplastic anemia.
Nair V; Sondhi V; Sharma A; Das S; Sharma S
Indian Pediatr; 2012 May; 49(5):371-6. PubMed ID: 22080620
[TBL] [Abstract][Full Text] [Related]
2. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
[TBL] [Abstract][Full Text] [Related]
3. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
[TBL] [Abstract][Full Text] [Related]
4. Outcome of children with aplastic anemia treated with immunosuppressive therapy.
Pongtanakul B; Das PK; Charpentier K; Dror Y
Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069
[TBL] [Abstract][Full Text] [Related]
5. Antithymocyte globulin and cyclosporine in children with aplastic anemia: a developing country experience.
Sharma R; Chandra J; Sharma S; Pemde H; Singh V
J Pediatr Hematol Oncol; 2012 Mar; 34(2):93-5. PubMed ID: 22278201
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of immunosuppressive therapy for children with aplastic anemia].
Wang YC; Yin CY; Feng L; Wang CM; Ma LN; Wei YW; Sheng GY
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jan; 14(1):33-7. PubMed ID: 22289749
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive therapy in adults with aplastic anaemia: single-institution experience from India.
Nair V; Sharma A; Das S; Sondhi V; Sharma S
Postgrad Med J; 2013 Sep; 89(1055):508-15. PubMed ID: 23686628
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia.
Kojima S; Hibi S; Kosaka Y; Yamamoto M; Tsuchida M; Mugishima H; Sugita K; Yabe H; Ohara A; Tsukimoto I
Blood; 2000 Sep; 96(6):2049-54. PubMed ID: 10979946
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.
Scheinberg P; Wu CO; Nunez O; Young NS
J Pediatr; 2008 Dec; 153(6):814-9. PubMed ID: 18672253
[TBL] [Abstract][Full Text] [Related]
10. Rabbit antithymocyte globulin treatment in childhood acquired severe aplastic anemia.
Karapinar DY; Karadaş N; Ay Y; Akin M; Balkan C; Aydinok Y; Kavakli K
Pediatr Hematol Oncol; 2014 Feb; 31(1):20-8. PubMed ID: 23627541
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of immunosuppressant therapy with lower dose of antithymocyte globulin and cyclosporine in aplastic anemia.
Malhotra P; Bodh V; Guru Murthy GS; Datta AK; Varma N; Varma S
Hematology; 2015 May; 20(4):239-44. PubMed ID: 25181305
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens.
Zheng Y; Liu Y; Chu Y
Exp Hematol; 2006 Jul; 34(7):826-31. PubMed ID: 16797409
[TBL] [Abstract][Full Text] [Related]
13. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Di Bona E; Rodeghiero F; Bruno B; Gabbas A; Foa P; Locasciulli A; Rosanelli C; Camba L; Saracco P; Lippi A; Iori AP; Porta F; De Rossi G; Comotti B; Iacopino P; Dufour C; Bacigalupo A
Br J Haematol; 1999 Nov; 107(2):330-4. PubMed ID: 10583220
[TBL] [Abstract][Full Text] [Related]
14. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
Chen C; Fang JP; Huang SL; Zhong FY
Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of severe aplastic anemia in children using standardized immunosuppressive therapy with antithymocyte globulin and cyclosporine A.
Goldenberg NA; Graham DK; Liang X; Hays T
Pediatr Blood Cancer; 2004 Dec; 43(7):718-22. PubMed ID: 15390303
[TBL] [Abstract][Full Text] [Related]
16. [Combination of rabbit antithymocyte globulin and cyclosporine A as first-line therapy for adult severe aplastic anemia].
Cao HM; Wang HJ; Zhang L; Jing LP; Zhou K; Yang DL; Li HQ; Liu QG; Yan ZS; Liu YZ; Wu YH; Chu YL; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):38-42. PubMed ID: 21429400
[TBL] [Abstract][Full Text] [Related]
17. Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan.
Teramura M; Kimura A; Iwase S; Yonemura Y; Nakao S; Urabe A; Omine M; Mizoguchi H
Blood; 2007 Sep; 110(6):1756-61. PubMed ID: 17526862
[TBL] [Abstract][Full Text] [Related]
18. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
Zhang X; Li Z; Geng W; Song B; Wan C
Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
[TBL] [Abstract][Full Text] [Related]
19. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus as an alternative to cyclosporine in the maintenance phase of immunosuppressive therapy for severe aplastic anemia in children.
Alsultan A; Goldenberg NA; Kaiser N; Graham DK; Hays T
Pediatr Blood Cancer; 2009 May; 52(5):626-30. PubMed ID: 19148946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]